메뉴 건너뛰기




Volumn 6, Issue 10, 2001, Pages 495-498

Pharmacogenomics: Challenges and opportunities

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; NEW DRUG;

EID: 0035339210     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(01)01761-5     Document Type: Editorial
Times cited : (14)

References (19)
  • 1
    • 0032829233 scopus 로고    scopus 로고
    • Pharmacogenomics and the changing face of clinical pharmacology
    • D.M. Grant Pharmacogenomics and the changing face of clinical pharmacology Can. J. Clin. Pharmacol. 7 1999 131 132
    • (1999) Can. J. Clin. Pharmacol. , vol.7 , pp. 131-132
    • Grant, D.M.1
  • 2
    • 85120132461 scopus 로고    scopus 로고
    • L.R.C. Agnew 15th Edn Dorland's Biomedical Market Place Healthcare Guide 1 1999 W.B. Saunders 1027
    • (1999) , pp. 1027
  • 3
    • 0032547341 scopus 로고    scopus 로고
    • Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4
    • T.R. Rebbeck Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4 J. Natl. Cancer Inst. 90 1998 1225 1229
    • (1998) J. Natl. Cancer Inst. , vol.90 , pp. 1225-1229
    • Rebbeck, T.R.1
  • 4
    • 13144282667 scopus 로고    scopus 로고
    • Association of CYP3A4 genotype with treatment-related leukemia
    • C.A. Felix Association of CYP3A4 genotype with treatment-related leukemia Proc. Natl. Acad. Sci. U. S. A. 95 1998 13176 13181
    • (1998) Proc. Natl. Acad. Sci. U. S. A. , vol.95 , pp. 13176-13181
    • Felix, C.A.1
  • 5
    • 0032748555 scopus 로고    scopus 로고
    • Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?
    • D.W. Nebert Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist? Clin. Genet. 56 1999 247 258
    • (1999) Clin. Genet. , vol.56 , pp. 247-258
    • Nebert, D.W.1
  • 6
    • 0032402838 scopus 로고    scopus 로고
    • Pharmacogenomics – it's not just pharmacogenetics
    • D.S. Bailey Pharmacogenomics – it's not just pharmacogenetics Curr. Opin. Biotechnol. 9 1998 595 601
    • (1998) Curr. Opin. Biotechnol. , vol.9 , pp. 595-601
    • Bailey, D.S.1
  • 7
    • 0032549039 scopus 로고    scopus 로고
    • Effect of the peroxisome proliferator ciprofibrate on hepatic cyclooxygenase and phospholipase A2 in rats
    • 2 in rats Toxicology 126 1998 65 73
    • (1998) Toxicology , vol.126 , pp. 65-73
    • Leung, L.K.1    Glauert, H.P.2
  • 8
    • 0033569516 scopus 로고    scopus 로고
    • Pharmacogenomics: translating functional genomics into rational therapeutics
    • W.E. Evans M.V. Relling Pharmacogenomics: translating functional genomics into rational therapeutics Science 286 1999 487 491
    • (1999) Science , vol.286 , pp. 487-491
    • Evans, W.E.1    Relling, M.V.2
  • 9
    • 0025868355 scopus 로고
    • Impact of environmental and genetic factors on codeine analgesia
    • J. Desmeules Impact of environmental and genetic factors on codeine analgesia Eur. J. Clin. Pharmacol. 41 1991 23 26
    • (1991) Eur. J. Clin. Pharmacol. , vol.41 , pp. 23-26
    • Desmeules, J.1
  • 10
    • 0034641736 scopus 로고    scopus 로고
    • Complex promoter and coding region β 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness
    • C.M. Drysdale Complex promoter and coding region β 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness Proc. Natl. Acad. Sci. U. S. A. 97 2000 10483 10488
    • (2000) Proc. Natl. Acad. Sci. U. S. A. , vol.97 , pp. 10483-10488
    • Drysdale, C.M.1
  • 11
    • 84984760488 scopus 로고    scopus 로고
    • Research suggests importance of haplotypes over SNPs
    • S. Davidson Research suggests importance of haplotypes over SNPs Nat. Biotechnol. 18 2000 1134 1135
    • (2000) Nat. Biotechnol. , vol.18 , pp. 1134-1135
    • Davidson, S.1
  • 12
    • 0032847892 scopus 로고    scopus 로고
    • Pharmacogenetics, genomics, proteomics: the new frontiers in drug development
    • C. Moyses Pharmacogenetics, genomics, proteomics: the new frontiers in drug development J. Pharma. Med. 13 1999 197 202
    • (1999) J. Pharma. Med. , vol.13 , pp. 197-202
    • Moyses, C.1
  • 13
  • 14
    • 0033529188 scopus 로고    scopus 로고
    • Single-nucleotide polymorphisms can cause different structural folds of mRNA
    • L.X. Shen Single-nucleotide polymorphisms can cause different structural folds of mRNA Proc. Natl. Acad. Sci. U. S. A. 96 1999 7871 7876
    • (1999) Proc. Natl. Acad. Sci. U. S. A. , vol.96 , pp. 7871-7876
    • Shen, L.X.1
  • 15
    • 0032814639 scopus 로고    scopus 로고
    • Current and future applications of pharmacogenomics
    • W.H. Anderson Current and future applications of pharmacogenomics Science Practice Acute Med. 7 1999 262 269
    • (1999) Science Practice Acute Med. , vol.7 , pp. 262-269
    • Anderson, W.H.1
  • 16
    • 0032415093 scopus 로고    scopus 로고
    • High throughput analysis of differential gene expression
    • J.P. Carulli High throughput analysis of differential gene expression J. Cell. Biochem. Suppl. 30/31 1998 286 296
    • (1998) J. Cell. Biochem. Suppl. , vol.30/31 , pp. 286-296
    • Carulli, J.P.1
  • 17
    • 84993811145 scopus 로고    scopus 로고
    • Innovation deficit revisited: reflections on the productivity of R&D
    • J.S. Drews S. Ryser Innovation deficit revisited: reflections on the productivity of R&D Drug Inf. J. 30 1996 97 108
    • (1996) Drug Inf. J. , vol.30 , pp. 97-108
    • Drews, J.S.1    Ryser, S.2
  • 18
    • 0032522873 scopus 로고    scopus 로고
    • Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies
    • J. Lazarou Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies J. Am. Med. Assoc. 279 1998 1200 1205
    • (1998) J. Am. Med. Assoc. , vol.279 , pp. 1200-1205
    • Lazarou, J.1
  • 19
    • 0035895505 scopus 로고    scopus 로고
    • The sequence of the human genome
    • J.C. Venter The sequence of the human genome Science 291 2001 1304 1351
    • (2001) Science , vol.291 , pp. 1304-1351
    • Venter, J.C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.